{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:43:48Z","timestamp":1773657828273,"version":"3.50.1"},"reference-count":38,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"DOI":"10.1590\/1414-431x20198793","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T12:57:39Z","timestamp":1579870659000},"source":"Crossref","is-referenced-by-count":9,"title":["Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and apoptosis pathways"],"prefix":"10.1590","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-2397","authenticated-orcid":false,"given":"Zhengbo","family":"Zhao","sequence":"first","affiliation":[{"name":"Jiulongpo District People's Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0477-1537","authenticated-orcid":false,"given":"Han","family":"Liu","sequence":"additional","affiliation":[{"name":"Jiulongpo District People's Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7332-380X","authenticated-orcid":false,"given":"Dongmei","family":"Guo","sequence":"additional","affiliation":[{"name":"Nanchuan District People's Hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2020]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.108.826214","article-title":"Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy","volume":"119","author":"Solomon SD","year":"2009","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/15376516.2012.666650","article-title":"Oxidative stress and cardiac hypertrophy: a review","volume":"22","author":"Maulik SK","year":"2012","journal-title":"Toxicol Mech Methods"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7150\/ijbs.11883","article-title":"Functions of autophagy in pathological cardiac hypertrophy","volume":"11","author":"Li Z","year":"2015","journal-title":"Int J Biol Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu I","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt\/mTOR and NFkappaB signaling pathways","volume":"131","author":"Zhao QD","year":"2015","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7150\/ijbs.17617","article-title":"PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT\/mTOR pathway","volume":"13","author":"Zhao D","year":"2017","journal-title":"Int J Biol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2017.03.087","article-title":"KLF15 protects against isoproterenol-induced cardiac hypertrophy via regulation of cell death and inhibition of Akt\/mTOR signaling","volume":"487","author":"Gao L","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11596-013-1205-9","article-title":"Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy","volume":"33","author":"Du M","year":"2013","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"C1256","DOI":"10.1152\/ajpcell.00338.2010","article-title":"mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy","volume":"299","author":"Song X","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jcp.21197","article-title":"Activation or inactivation of cardiac Akt\/mTOR signaling diverges physiological from pathological hypertrophy","volume":"214","author":"Kemi OJ","year":"2008","journal-title":"J Cell Physiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/hr.2010.182","article-title":"Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice","volume":"33","author":"Li L","year":"2010","journal-title":"Hypertens Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.amjcard.2010.11.033","article-title":"Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and beta blockers in patients with idiopathic dilated cardiomyopathy","volume":"107","author":"Hoshikawa E","year":"2011","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.HYP.0000101688.17370.87","article-title":"Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren","volume":"42","author":"Stanton A","year":"2003","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/15376516.2015.1128035","article-title":"Effect of aliskiren and carvedilol on expression of Ca(2+)\/calmodulin-dependent protein kinase II delta-subunit isoforms in cardiac hypertrophy rat model","volume":"26","author":"Bin-Dayel AF","year":"2016","journal-title":"Toxicol Mech Methods"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/08037050701717014","article-title":"Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension","volume":"16","author":"Verdecchia P","year":"2007","journal-title":"Blood Press"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ajh.2011.3","article-title":"Aliskiren vs. angiotensin receptor blockers in hypertension: meta-analysis of randomized controlled trials","volume":"24","author":"Gao D","year":"2011","journal-title":"Am J Hypertens"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/hr.2012.185","article-title":"Aliskiren vs. other antihypertensive drugs in the treatment of hypertension: a meta-analysis","volume":"36","author":"Chen Y","year":"2013","journal-title":"Hypertens Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/aps.2014.45","article-title":"Aliskiren ameliorates pressure overload-induced heart hypertrophy and fibrosis in mice","volume":"35","author":"Weng LQ","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1479-5876-11-130","article-title":"A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats","volume":"11","author":"Chowdhury D","year":"2013","journal-title":"J Transl Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11010-017-3253-0","article-title":"Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat","volume":"445","author":"Saleem N","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak KJ","year":"2001","journal-title":"Methods"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e63583","DOI":"10.1371\/journal.pone.0063583","article-title":"A simple high-content cell cycle assay reveals frequent discrepancies between cell number and ATP and MTS proliferation assays","volume":"8","author":"Chan GK","year":"2013","journal-title":"PLoS One"},{"key":"ref23","first-page":"1566","article-title":"Circular RNA circ-ABCB10 promotes breast cancer proliferation and progression through sponging miR-1271","volume":"7","author":"Liang HF","year":"2017","journal-title":"Am J Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.metabol.2012.12.012","article-title":"Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling","volume":"62","author":"Whaley-Connell A","year":"2013","journal-title":"Metabolism"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00059-013-3849-4","article-title":"Sulforaphane protects H9c2 cardiomyocytes from angiotensin II-induced hypertrophy","volume":"39","author":"Wu QQ","year":"2014","journal-title":"Herz"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","article-title":"Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line","volume":"58","author":"Tse MM","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bcpt.12405","article-title":"l-arginine attenuates cardiac dysfunction, but further down-regulates alpha-myosin heavy chain expression in isoproterenol-induced cardiomyopathy","volume":"117","author":"Kralova E","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.4161\/auto.26447","article-title":"MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1","volume":"9","author":"Wang Y","year":"2013","journal-title":"Autophagy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2012.11.001","article-title":"mTOR: on target for novel therapeutic strategies in the nervous system","volume":"19","author":"Maiese K","year":"2013","journal-title":"Trends Mol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"F267","DOI":"10.1152\/ajprenal.00629.2014","article-title":"mTOR contributes to ER stress and associated apoptosis in renal tubular cells","volume":"308","author":"Dong G","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1074248415581177","article-title":"The AMPK Agonist PT1 and mTOR inhibitor 3HOI-BA-01 protect cardiomyocytes after ischemia through induction of autophagy","volume":"21","author":"Huang L","year":"2016","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2015.07.065","article-title":"Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy","volume":"464","author":"Liu B","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.yexmp.2014.04.004","article-title":"Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN","volume":"96","author":"Rai P","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3389\/fphar.2017.00819","article-title":"Aliskiren improves ischemia- and oxygen glucose deprivation-induced cardiac injury through activation of autophagy and AMP-activated protein kinase","volume":"8","author":"Chiang MH","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/HYPERTENSIONAHA.108.116350","article-title":"Renin inhibition improves cardiac function and remodeling after myocardial infarction independent of blood pressure","volume":"52","author":"Westermann D","year":"2008","journal-title":"Hypertension"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jcmm.12273","article-title":"Aliskiren-attenuated myocardium apoptosis via regulation of autophagy and connexin-43 in aged spontaneously hypertensive rats","volume":"18","author":"Zhang W","year":"2014","journal-title":"J Cell Mol Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1159\/000430322","article-title":"Calhex 231 ameliorates cardiac hypertrophy by inhibiting cellular autophagy in vivo and in vitro","volume":"36","author":"Liu L","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2014.01.061","article-title":"Berberine improves pressure overload-induced cardiac hypertrophy and dysfunction through enhanced autophagy","volume":"728","author":"Li MH","year":"2014","journal-title":"Eur J Pharmacol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v53n2\/1414-431X-bjmbr-53-2-e8793.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T17:26:48Z","timestamp":1722360408000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2020000200602&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"alternative-id":["S0100-879X2020000200602"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x20198793","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"article-number":"e8793"}}